A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.

NCT01088659 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis D, Chronic

Interventions

DRUG: peginterferon alfa-2a [Pegasys]
DRUG: placebo
DRUG: tenofovir

Sponsor

Hoffmann-La Roche